Heart study seeks to uncover why some Thick-Heart patients fare worse
NCT ID NCT07006974
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study looks at 165 people with two different types of heart muscle thickening: syndromic/metabolic cardiomyopathy (SMCs) and hypertrophic cardiomyopathy (HCM). Researchers want to see if SMCs patients have worse heart outcomes like death or heart failure, and what risk factors might predict a poor prognosis. The study does not test any new treatment, but aims to improve understanding of these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart scans may unlock hidden risks in minority communities
- Global registry aims to unlock clues for heart transplant success in adults born with heart defects
- Heart conditions in kids: study reveals impact on daily life and play
- Could a simple scan unlock better heart treatment?